Distribution records in the pharmaceutical industry connect a shipped drug product with its recipient, shipment date, quantity, and lot or control number. Accurate records support traceability, quality investigations, and recall execution. They need to be usable when a decision is urgent, not merely available somewhere in an archive.
What does 21 CFR 211.196 require?
For finished pharmaceuticals within its scope, 21 CFR 211.196 specifies the product name, strength, dosage-form description, consignee name and address, shipment date and quantity, and drug-product lot or control number.
| Required information | Why it matters operationally |
|---|---|
| Product name, strength, and dosage form | Distinguishes presentations that may have similar names or packaging. |
| Consignee name and address | Identifies the recipient to contact during an investigation or recall. |
| Date and quantity shipped | Supports reconciliation and assessment of the affected distribution period. |
| Lot or control number | Connects each shipment to the relevant batch history. |
Use the current applicable regulatory framework. The present text of 21 CFR 211.196 no longer includes the historical compressed-medical-gas exception. Medical gases have a separate cGMP framework in Part 213, so assess the applicable requirements rather than relying on an older exception.
Build traceability into the distribution workflow
Define how lot information moves from batch release and inventory into picking, shipment confirmation, and retained records. Identify the authoritative record and the people responsible for resolving discrepancies between systems.
- Confirm product identity. Match the correct presentation and released status before shipment.
- Capture the consignee. Keep recipient information complete and distinguish billing from shipment details where relevant.
- Record the transaction. Retain shipment quantities and lot identifiers in a retrievable format.
- Reconcile exceptions. Review returns, replacements, split shipments, and corrected records through defined controls.
- Test retrieval. Check that staff can reconstruct the distribution history for a selected lot.
How distribution records support recalls
A recall team needs to identify affected recipients and quantities promptly. A useful readiness exercise starts with a lot and asks the team to retrieve all associated shipments, explain any gaps, and reconcile the result with inventory and other relevant records.
Document the search method, the data sources, unresolved discrepancies, and corrective actions. Do not assume that an enterprise resource planning system automatically provides a complete distribution history across warehouses or contracted partners.
Quality control and data integrity
Control who can create, change, and approve records. Preserve the relationship between original entries and corrections, and define how electronic records remain available after system changes or migrations. Evaluate applicable electronic-record requirements rather than treating a software purchase as a compliance solution.
Where a third party handles warehousing or distribution, clarify record ownership, access, retention, retrieval timing, and issue escalation in the relevant agreements. BioBoston Consulting provides internal and supplier audit support to assess controls and evidence across outsourced operations.
Common pharmaceutical distribution record gaps
- Lot numbers captured inconsistently across shipment systems.
- Incomplete recipient addresses or outdated contact information.
- Product presentations that cannot be reliably distinguished.
- Uncontrolled spreadsheet corrections and missing source records.
- Returns and replacements excluded from reconciliation.
- Records held by a logistics provider without a tested retrieval process.
A practical review checklist
Select a representative shipment and confirm that each required field can be traced to supporting evidence. Then select a lot and test whether all relevant shipments can be reconstructed. These two directions expose different weaknesses: transaction completeness and lot-level retrieval.
Record who performed the review, which systems and dates were covered, what could not be reconciled, and the owner of each follow-up action.
Common questions about pharmaceutical distribution records
How long must pharmaceutical distribution records be retained?
For batch-associated records covered by 21 CFR 211.180(a), retain them for at least one year after batch expiration. For certain OTC products exempt from expiration dating under 21 CFR 211.137, the period is three years after distribution. Assess additional applicable commitments and documented holds before disposal.
Are distribution records and DSCSA tracing records the same thing?
They address related traceability needs but should not be treated as interchangeable obligations. This article covers finished-pharmaceutical distribution records under Part 211. Assess separately whether the product, transaction, and trading partner are subject to Drug Supply Chain Security Act requirements.
Can a third-party logistics provider hold the distribution records?
Outsourced storage should preserve the responsible organization’s ability to retrieve complete records and support investigations. Define ownership, access, retention, corrections, and retrieval expectations in the agreement. Test a lot-level retrieval before relying on the provider during a recall.
Sources and regulatory references
References checked November 5, 2026. Regulations set binding obligations; agency guidance provides recommendations. Apply the sources within their stated scope and the requirements relevant to your product, activity, and jurisdiction.
